Physician profile
Simon N Smith
NPI 1740532613
$1,927.04
in general payments reported to CMS, 2019-2025
8 companies · $349 in 2025
The $349 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $23.59 · 2023: $41.04 · 2024: $1,513 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,132 · Food and Beverage: $771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,132.27 |
| Food and Beverage | $771.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,614.87 | 2023-2025 | Abre, Inceptiv, Closurefast |
| Zynex Medical, INC. | $173.09 | 2025 | Nexwave |
| Precision Medical Products INC. | $42.96 | 2024 | Xstim Spinal Fusion Stimulator |
| Smith+Nephew, INC. | $33.53 | 2024 | Stravix Pl, Grafix Pl |
| Depuy Synthes Sales INC. | $24.26 | 2025 | Milagro, Dynatape, Truespan Orthocord |
| Zimvie INC. | $23.59 | 2022 | |
| Tactile Systems Technology INC | $14.74 | 2023 | Flexitouch Plus, Entre Plus |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.